Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
EXTL1
Introduction
Exostosin-like 1 is a protein that in humans is encoded by the EXTL1 gene.[1][2]
This gene is a member of the multiple exostoses (EXT) family of glycosyltransferases, which function in the chain polymerization of heparan sulfate and heparin. The encoded protein harbors alpha 1,4- N-acetylglucosaminyltransferase activity, and is involved in chain elongation of heparan sulfate and possibly heparin.[2]
References
References
- ↑ Wise CA, Clines GA, Massa H, Trask BJ, Lovett M (May 1997). “Identification and localization of the gene for EXTL, a third member of the multiple exostoses gene family”. Genome Res. 7 (1): 10–6. doi:10.1101/gr.7.1.10. PMID 9037597.
- ↑ 2.0 2.1 “Entrez Gene: EXTL1 exostoses (multiple)-like 1”.
Further reading
Further reading
- Zak BM, Crawford BE, Esko JD (2003). “Hereditary multiple exostoses and heparan sulfate polymerization”. Biochim. Biophys. Acta. 1573 (3): 346–55. doi:10.1016/S0304-4165(02)00402-6. PMID 12417417.
- Xu L, Xia J, Jiang H, et al. (1999). “Mutation analysis of hereditary multiple exostoses in the Chinese”. Hum. Genet. 105 (1–2): 45–50. doi:10.1007/s004390051062. PMID 10480354.
- Wuyts W, Spieker N, Van Roy N, et al. (2000). “Refined physical mapping and genomic structure of the EXTL1 gene”. Cytogenet. Cell Genet. 86 (3–4): 267–70. doi:10.1159/000015317. PMID 10575224.
- Kim BT, Kitagawa H, Tamura J, et al. (2001). “Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode α1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis”. Proc. Natl. Acad. Sci. U.S.A. 98 (13): 7176–81. doi:10.1073/pnas.131188498. PMC 34642. PMID 11390981.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Mathysen D, Van Roy N, Van Hul W, et al. (2004). “Molecular analysis of the putative tumour-suppressor gene EXTL1 in neuroblastoma patients and cell lines”. Eur. J. Cancer. 40 (8): 1255–61. doi:10.1016/j.ejca.2004.01.013. PMID 15110891.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Kimura K, Wakamatsu A, Suzuki Y, et al. (2006). “Diversification of transcriptional modulation: Large-scale identification and characterization of putative alternative promoters of human genes”. Genome Res. 16 (1): 55–65. doi:10.1101/gr.4039406. PMC 1356129. PMID 16344560.
- Gregory SG, Barlow KF, McLay KE, et al. (2006). “The DNA sequence and biological annotation of human chromosome 1”. Nature. 441 (7091): 315–21. doi:10.1038/nature04727. PMID 16710414.